Ixazomib and Dexamethasone With or Without Venetoclax in Treating Patients With Non-t(11;14) Relapsed or Refractory Multiple Myeloma

Name: Ixazomib and Dexamethasone With or Without Venetoclax in Treating Patients With Non-t(11;14) Relapsed or Refractory Multiple Myeloma
Published: 2019
License: Public Domain

National Cancer Institute (NCI) · 2019

ClinicalTrials.gov · Datasets · License: Public Domain · 2019

Open Source ↗

recurrent plasma cell myeloma, refractory plasma cell myeloma, t(11;14) negative, interventional, phase1, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Ixazomib and Dexamethasone With or Without Venetoclax in Treating Patients With Non-t(11;14) Relapsed or Refractory Multiple Myeloma

Related documents